Spruce Biosciences Inc. (SPRB) NASDAQ

$2.18 0.18 (8.75%)

Market Cap: $47.12M

As of 08/15/22 10:55 AM EDT. Market open.

(SPRB)

Spruce Biosciences Inc. (SPRB) NASDAQ

$2.18 0.18 (8.75%)

Market Cap: $47.12M

As of 08/15/22 10:55 AM EDT. Market open.

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a ... read more

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess, representing 3-5% of females with PCOS (estimated to be 150,000 to 200,000 patients in the United States). read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
17
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$2.07
Previous Close
$2
Days Range
$2 - $2.14
52 week range
$1.25 - $8.59
Volume
20,125
Avg. Volume (30 days)
29,376
Market Cap
$47.12M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
23,560,250
Open
$2.07
Previous Close
$2
Days Range
$2 - $2.14
52 week range
$1.25 - $8.59
Volume
20,125
Avg. Volume (30 days)
29,376
Market Cap
$47.12M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
23,560,250

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SPRUCE BIOSCIENCES INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Gharib Samir M. President & CFO Jun 30, 2022 Option Exercise $1.48 5,446 8,055 46,578 Jul 05, 2022, 04:04 PM
Gharib Samir M. President & CFO Jun 30, 2022 Option Exercise $1.74 12,968 22,564 33,610 Jul 05, 2022, 04:04 PM
SIMPSON CAMILLA V Director May 20, 2021 Option Exercise $0.85 334 284 334 May 21, 2021, 09:10 PM
SIMPSON CAMILLA V Director May 20, 2021 Sale $15.29 334 5,107 0 May 21, 2021, 09:10 PM
Novo Holdings A/S 10% Owner May 19, 2021 Sale $13.90 475,000 6,602,500 4,514,336 May 21, 2021, 04:32 PM
SIMPSON CAMILLA V Director Apr 30, 2021 Option Exercise $0.85 14,045 11,938 14,045 May 04, 2021, 09:09 PM
SIMPSON CAMILLA V Director Apr 30, 2021 Sale $16.14 14,045 226,664 0 May 04, 2021, 09:09 PM
Novo Holdings A/S 10% Owner Oct 14, 2020 Buy $15.00 250,000 3,750,000 4,989,336 Oct 16, 2020, 04:49 PM
RiverVest Venture Fund III, L.P. 10% Owner Oct 14, 2020 Buy $15.00 250,000 3,750,000 2,148,281 Oct 16, 2020, 12:34 PM
Muralidhar Bali Director Oct 14, 2020 Buy $15.00 200,000 3,000,000 1,792,518 Oct 16, 2020, 12:24 PM
O'Donnell Niall Director Oct 14, 2020 Buy $15.00 250,000 3,750,000 695,905 Oct 16, 2020, 12:21 PM
Omega Fund VI, L.P. Former 10% Owner Oct 14, 2020 Buy $15.00 250,000 3,750,000 2,161,022 Oct 16, 2020, 12:15 PM
Chaya Moghrabi Dina Director Oct 14, 2020 Buy $15.00 250,000 3,750,000 2,161,022 Oct 16, 2020, 12:14 PM
HealthCap VIII, L.P. Former 10% Owner Oct 14, 2020 Buy $15.00 250,000 3,750,000 2,033,621 Oct 16, 2020, 12:08 PM
HANSSON JONAS Director Oct 14, 2020 Buy $15.00 250,000 3,750,000 2,033,621 Oct 16, 2020, 12:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Gharib Samir M. President & CFO 06/30/2022 8,055
Gharib Samir M. President & CFO 06/30/2022 22,564
SIMPSON CAMILLA V Director 05/20/2021 284
SIMPSON CAMILLA V Director 05/20/2021 5,107
Novo Holdings A/S 10% Owner 05/19/2021 6,602,500
SIMPSON CAMILLA V Director 04/30/2021 11,938
SIMPSON CAMILLA V Director 04/30/2021 226,664
Novo Holdings A/S 10% Owner 10/14/2020 3,750,000
RiverVest Venture Fund III, L.P. 10% Owner 10/14/2020 3,750,000
Muralidhar Bali Director 10/14/2020 3,000,000
O'Donnell Niall Director 10/14/2020 3,750,000
Omega Fund VI, L.P. Former 10% Owner 10/14/2020 3,750,000
Chaya Moghrabi Dina Director 10/14/2020 3,750,000
HealthCap VIII, L.P. Former 10% Owner 10/14/2020 3,750,000
HANSSON JONAS Director 10/14/2020 3,750,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
03/31/2022
0%
1Q
06/30/2022
12/31/2021
0.56%
2Q
06/30/2022
09/30/2021
0.70%
3Q
06/30/2022
06/30/2021
0.80%
4Q
06/30/2022
03/31/2021
0.90%
5Q
Load More

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2022
0%
1Q
12/31/2021
0.56%
2Q
09/30/2021
0.70%
3Q
06/30/2021
0.80%
4Q
03/31/2021
0.90%
5Q
Load More